Last reviewed · How we verify
Effectiveness and Safety of Combination Mifepristone/Misoprostol for Medical Abortion (MiMAC)
National multi-center non interventional study aiming at investigating the effectiveness and safety of the combination mifepristone-misoprostol prescribed in Canada to women for medical termination of pregnancy at or before 63 days gestational age through a multi-center prospective non interventional study design.
Details
| Lead sponsor | Linepharma International LTD |
|---|---|
| Status | TERMINATED |
| Enrolment | 129 |
| Start date | Sat Feb 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Tue Feb 20 2024 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Medical Abortion
Interventions
- Mifepristone-Misoprostol
Countries
Canada